5-aminolevulinic acid (5-ALA)

DRUG3 trials

Sponsors

medac GmbH, University of Hawaii, Dartmouth-Hitchcock Medical Center

Conditions

AmputationBrain CancerBrain Tumor, PrimaryBrain TumorsCancer of BrainCoping BehaviorInsomniaIrritability

Phase 3

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

CompletedNCT00241670

medac GmbHBrain Cancer, Brain Tumor, Primary, Brain Tumors +2

Start: 1999-10-31Updated: 2012-04-26

Unknown Phase

Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood

CompletedNCT01508741

University of HawaiiCoping Behavior, Insomnia, Irritability +2

Start: 2012-01-31End: 2012-12-31Updated: 2013-03-20

Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients

Not yet recruitingNCT06777511

Dartmouth-Hitchcock Medical CenterAmputation, Osseointegration

Start: 2026-10-01End: 2028-10-01Target: 10Updated: 2026-07-29

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

2006-05-012273 citations